Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Evaluate the Impact of MRSA Nasal Screen Implementation.
Sponsor: Methodist Health System
Summary
To evaluate the impact of MRSA nasal screen implementation on duration of therapy and cost associated with vancomycin use.
Official title: The Effect of MRSA Nasal Screen Implementation on Duration of Therapy and Cost Associated With Vancomycin Use.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
21
Start Date
2019-10-01
Completion Date
2026-06-10
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
Duration of therapy
The final data will then be compared to determine if the duration of therapy and cost after implementation of the MRSA nasal screen if significantly different from before the implementation of the MRSA nasal screen.
Direct Cost
Direct costs of vancomycin for each treatment arm (in US dollars).
Pharmacokinectic Monitoring
Number of vancomycin levels drawn for pharmacokinetic monitoring.
Hospital stay
Length of hospital stay in days
Locations (1)
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, United States